Skip to main content

Table 4 MIC50 (μg/mL) of ZnO-NPs and drugs-loaded ZnO-NPs suspension against Gram-negative and Gram-positive bacteria

From: Zinc oxide nanoparticles conjugated with clinically-approved medicines as potential antibacterial molecules

Bacteria CEFT ZnO-CEFT QTG ZnO-QTG NAR ZnO-NAR AMB ZnO-AMB AMPI ZnO-AMPI ZnONPs
MIC50 MIC50 MIC50 MIC50 MIC50 MIC50 MIC50 MIC50 MIC50 MIC50 MIC50
E. coli K1 23 14 > 500 > 500 > 500 > 500 > 500 > 500 123 64 290
P. aeruginosa 130 128 > 500 340 > 500 > 500 > 500 390 110 95 255
S. marcescens 55 19 310 245 350 275 470 325 56 21 245
MRSA 16 4 400 114 > 500 270 > 500 236 170 118 158
S. pyogenes 14 6 340 125 420 189 485 210 26 18 130
S. pneumoniae 11 4 90 55 88 52 > 500 270 22 9 95